In conclusion, HSP90 inhibition by RGRN-305 potently suppressed inflammation using in vitro and in vivo experimental models mimicking AD, providing evidence that HSP90 inhibition may be a novel mechanism of action in treating AD. This evidence concerns the gene HSP90AA1 and Alzheimer disease.